Latest News

Promising chronic pain drug developed

A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • It?s easier to learn words that sound like what they mean

  • First nationwide survey of climate change education

  • Mommy and me: Study shows how affectionate mothering can combat the effects of maternal depression

  • Male biology students consistently underestimate female peers, study finds

  • Will you be turning left or right for that Valentine?s Day kiss: It?ll depend on who you?re kissing!

  • Novel neuroprotective therapy found to enhance memory

  • What 'tainted' engagement rings reveal about consumer expectations

  • Enhancing neuronal activity promotes axon regeneration in adult central nervous system

  • Computerized rehab aids those suffering from brain injuries

  • Lipid-based diets effectively combat Alzheimer's disease in mouse model

  •